Aim: Social, emotional, cognitive and language development of infants is provided with early diagnosis of hearing deficit. Hearing deficit is reported with a rate of 1-6 in 1000 live births in healthy newborns, while it reaches up to 10-30 in 1000 live births in newborns with risk factors. We aimed to compile the results of the hearing screening program applied in our hospital.
Introduction
Infants with hearing deficit can be evaluated in the most inexpensive way with hearing screening programs in the neonatal period and can be diagnosed definitely (1) (2) (3) . Social, emotional, cognitive and language development of infants is provided by early diagnosis of hearing deficit (4) (5) (6) . Hearing deficit is reported with a rate of 1-6 in 1000 live births in healthy newborns, while it reaches up to 10-30 in 1000 live births in newborns with risk factors (1, 7, 8) .
In our country, neonatal hearing screening started in Hacettepe and Marmara Universities for the first time. Since the year of 2000 maternity hospitals and other university hospitals have been added to the centers of screening and hearing screening is still being widely pursued (9) .
In this study, it was aimed to evaluate the clinical and demographic properties of the infants who were found to have hearing deficit as a result of the review of the hearing screening program results of Zekai Tahir Burak Women's Health Education and Research Hospital and determine the risk factors.
Material and Methods
The Zekai Tahir Burak Women's Health Education and Research Hospital hearing screening program records belonging to 2005-2011 were examined. Conduction of the study was accepted with the decision of Zekai Tahir Burak Women's Health Education and Research Hospital Education Planning Coordination Committee (dated 16.06.2011, number 11). Medical records of the patients who were found to have hearing deficit were reached and their sociodemographic and clinical properties and risk factors were evaluated. The patients were divided into two groups as the group with a gestational age (GA) below 32 weeks and the group with a gestational age above 32 weeks. Hearing screening was performed by an odiometrist before the infant is discharged including holiday periods using autoaucistic emission (TEOAE, transient evoked otoacoustic emissions) method. The patients who failed the test for the second time were asked to come back 5 days later for a follow-up visit. If negatif result was obtained on follow-up examination performed with TEOAE, the auditory brainstem response (ARB) test was performed. The infants who were found to have unilateral or bilateral hearing deficit were referred to Hacettepe University Department of Otolaryngology, Odiology-Speech Disorders Unit. Hearing tests were performed using Echo Screen (Natus Medical Incorporated, San Carlos, CA, USA) device.
Statistical analysis
Statistical Program for Social Sciences (SPSS, New York, USA, version 20,0) was used for statistical analysis of the data. Chisquare test was used in assessment of numerical data. In assessment of the data which were expressed as measurement, t-test an done-way variance analysis were used when the variability test met the assumptions and Mann-Whitney U test and Kruskall Wallis test were used when the variability test did not meet the assumptions. A p value of <0.05 was considered significant.
Results
Hearing test was performed in a total of 142 128 patients who were born in our hospital between 2005 and 2011 before discharge. 26 690 of these patients were evaluated with TEOAE for the second time and 2 412 patients were evaluated with TEOAE for the third time (Table 1) . 385 (0.27%) patients who Medical records of 171 of the patients who were found to have hearing deficit could be reached. 116 of these patients were followed up by hospitalization in the neonatal intensive care unit (NICU). 55 patients were not hospitalized in NICU. 49 of the patients had a gestationa age below 32 weeks ans 122 patients had a gestational age above 32 weeks. The median gestational age and birth weight were 35 weeks (22-43) and 2 140 g (580-4 590 g), respectively. 87 of the patients were female and 84 were male.
The risk factors of the patients were evaluated ( Table 2 ). Skeletal dysplasia (n=4), Down syndrome (n=3), cleft lip-palate (n=2), ventricular septal defect (n=2), atypical facial appearace (n=2), Smith-Lemni-Opitz syndrome (n=1), Treacher Collins syndrome (n=1), Pierre Robin syndrome (n=1), meningomyelocele (n=1), ichtiosis (n=1), microcephaly (n=1) were found in a total of 19 patients. Other risk factors included intrauterine growth reatardation (n=24), multiple pregnancy (n=22), hyperbilirubinemia (n=74), blood exchange because of hyperbilirubinemia (n=7), sepsis (n=52), hypoglycemia (n=2), use of aminoglycoside and glycopeptide (n=99), use of furosemide (n=27), mechanical ventilation theraphy (n=37), polystemia (n=12), prenatal asphyxia (n=2), respiratory distress syndrome (n=45), chronic lung disease (n=11), surgery for retinopathy of prematurity (n=8) and hearing deficit in the mother or father (n=7).
Intrauterine growth retardation, hyperbilirubinemia, sepsis and drug usage were found with a higher rate in the group with a lower gestational week (p<0.001). History of hearing deficit in the mother or father was present in 7 patients.
Discussion
Neonatal hearing screening is widely used in the whole world. Hearing screening which started in 1964 for the first time was performed primarily in patients who carried risk, whereas it is being performed in all infants currently (10, 11) . In the literature, the risk factors which lead to hearing deficit have been reported to include a familial history of hereditary hearing deficit, low birth weigth, hyperbilirubinemia, use of ototoxic drugs, sepsis, meningitis, low APGAR and presence of mechanical ventilation (12, 13) . While hearing deficit is expected in 2-5% of the infants who have these risk factors, no risk factor is found in 50% of the infants with hearing deficit (14, 15) .
During the study period, hearing screening was performed in 142 128 newborns in our hospital and hearing deficit was found in 385 patients (0.27%). This rate is compatible with the rate reported in the literature (0.1-0.6%) (1, 7, 16 ). When the studies performed in our country were examined, it was found that Genç et al. (17) In a study performed in Uludağ University, Eryılmaz et al. (19) found no hearing deficit in 402 infants. According to the results of neonatal scrrening performed in Denizli, Polatlı and İstanbul, the rates of hearing deficit were reported to range between 0.1% and 0.15% (20) (21) (22) . The finding that the rate hearing deficit found in our study was higher compared to the studies conducted in recent years may be explained with the fact that our study period was longer compared to the other studies, infants who were hospitalized in NICU were included in our study and the infants followed up in our hospital have more risk factors including premature delivery and congenital disorders compared to the other centers. In addition, it is notable that there is a decrease in the number of patients who are found to have hearing deficit in recent years in our hospital. This may be related with taking necesssary precautions by determining the risk factors which may lead to hearing deficit as well as improvement in prenatal care and the advancements made in the area of neonatology in recent years.
When the risk factors belonging to the infants who were found to have hearing deficit in our study were evaluated, it was observed that the most common risk factors included premature delivery, intrauterine growth reatardation, use of ototocix drugs including aminoglycozide, glycopeptide and furosemide, hyperbilirubinemia, exchange transfusion, sepsis, polystemia, various syndromes which especially involve the craniofacial region, mechanical ventilation therapy, familial history of hearing deficit and prenatal asphyxia. These risk factors should be considered when evaluating the patients. Especially premature infants have the potential to be exposed to multiple risk factors including hyperbilirubinemia, use of mechanical ventilation, sepsis and use of ototoxic drugs and the frequency of hearing deficit increases as the frequency of morbidity including retinopathy of prematurity and chronic lung disease increases. The risk factors which may facilitate hearing deficit should be determined when the patients are being followed up in NICUs and occurence of hearing deficit should be prevented by taking the necessary precautions. It should be kept in mind that hearing deficit are within the scope of the disease's natural course in clinical conditions including syndromes and cranio-facial anomalies and treatment should be initiated by making the diagnosis at an early period. The possibility of development of hearing deficit should be considered while determining the diagnostic, therapeutic and follow-up methods. In these patients, hearing tests should be repeated during the follow-up after discharge.
Türk Ped Arş 2014; 49: 138-41 Çelik et al. Assesment of hear screening results Our study is the largest study which reports neonatal hearing screening results and determines the risk factors in infants with hearing deficit in our country. Conclusively, hearing screening should be performed in each newborn baby and babies with risk factors should be determined, hearing deficit should be screened by repeated hearing tests and treatment should be started in a short period so that the baby's social, emotional, cognitive and language development is assured.
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